Macrocyclics Inc

Macrocyclics Inc. is a manufacturer of customized chelating agents based in Plano, Texas. The company employs 11 people and generates approximately $6 million in annual revenue. Macrocyclics provides a wide range of chelating agents, including both catalog products and custom cGMP products and services. Their target customers include researchers in basic and applied research, as well as those involved in early-stage clinical development programs. They also offer expert consulting services related to chelation chemistry and bioconjugation. Macrocyclics' research and development strategy focuses on meeting the evolving needs of the medical community. Their molecular imaging platform technology is adaptable to various radionuclides for positron emission tomography (PET) and magnetic resonance imaging (MRI). The company specializes in bifunctional ligands designed for bio-targeting applications, particularly in conjunction with monoclonal antibodies and peptide fragments. For more information, visit macrocyclics.com.